Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Alzheimer's Prediction And Diagnosis May Be Improved By Brain Imaging And Proteins In Spinal Fluid
Changes in the brain measured with MRI and PET scans, combined with memory tests and detection of risk proteins in body fluids, may lead to earlier and more accurate diagnosis of Alzheimer"s, according to new research reported at the Alzheimer"s Association 2009 International Conference on Alzheimer"s Disease (ICAD 2009) in Vienna.

Climate Change And Other Stresses Expected To Affect Entire Populations Of Fish
Entire populations of North American fish already are being affected by several emerging diseases, a problem that threatens to increase in the future with climate change and other stresses on aquatic ecosystems, according to a noted U.S. Geological Survey researcher gave an invited talk on this subject yesterday at the Wildlife Disease Association conference in Blaine, Wash.
News of the day
ZIOPHARM Presents Positive Darinaparsin Clinical Data At ASCO's Prestigious Clinical Science Symposium
ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that it presented positive data from both Phase II intravenous (IV) and Phase I oral studies of darinaparsin (ZinaparTM or ZIO-101), the novel organic arsenic molecule, as part of the prestigious Clinical Cancer Symposia at the 45th Annual American Society of Clinical Oncology (ASCO) meeting held in Orlando, FL, May 29th to June 2nd.
Sexual Health

Metabolic Disease Drug Discovery Conference: Monday September 21, 2009

on both Clinical and Business Fronts 3:00 Shaping Business Development Through Collaboration Ventures -- Identifying what are the requirements to establish early stage research collaborations -- Extending knowledge gathering beyond existing in-house capabilities -- Expanding the value of a partnership beyond a single deal -- Outsourcing lead finding and early development to partnering companies Dr. Dennis Kim, SVP, Metabolic Diseases, Orexigen Therapeutics Inc 3:45 Scientific Licensing Strategy & Process: Focus on Metabolic Disease Interests -- Outlining Merck"s scientific licensing strategy and review process -- Providing a review of the partnering process, including initiation and negotiation processes -- Identifying what Merck looks for in a potential therapeutic candidate -- Discussing specific licensing priorities for the metabolic diseases area Dr. Lauren Shearman, Associate Director, Scientific Liaison External Scientific Affairs, Merck 4:30 End of Conference IDGA

Pages: 1 [2] 

Team building activities commented:

It is essential to make soome stretegies for the effective reatment of various diseases. I really appreciate the motive of this conference.

25.04.2012


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009